Ondansetron
Product Images NDC 71872-7069

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71872-7069). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (700000)

Ondansetron Injection, USP 4 mg per 2 mL (2 mg per mL) single-dose vial label. The label specifies intravenous or intramuscular injection use, sterile and preservative-free. It lists inactive ingredients and storage instructions at 20 to 25°C. Manufactured for Athenex, Schaumburg, IL, and repackaged by Medical Purchasing Solutions, LLC, Scottsdale, AZ.*

FDA Label Image

Structural Formula (Ond07 0003 01)

Chemical structure diagram of ondansetron hydrochloride dihydrate showing its molecular framework including aromatic rings and functional groups.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ond07 0004 02)

Ondansetron Injection, USP 4 mg per 2 mL (2 mg per mL) single-dose vial label. The label indicates use for intravenous or intramuscular injection, sterile, nonpyrogenic, and preservative-free. Manufactured for Athenex, made in India, with a barcode and NDC 70860-776-02 visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.